Company intelligence / Profile preview

Prediction Sciences

San Diego, California, United Statespredictionsciences.com ↗

Ownership: Private
Development stage: Other

Overview

Prediction Sciences was a biotechnology company specializing in pharmacogenomics and the development of diagnostic tests to predict patient response to therapeutic treatments. The company utilized advanced data mining and predictive modeling to identify biomarkers that correlate with drug efficacy and toxicity. Its primary focus was on oncology and cardiovascular health, aiming to personalize medicine by ensuring patients receive the most effective treatments based on their genetic profiles. In 2008, the company was acquired by AltheaDx to bolster its diagnostic portfolio.

Therapeutic areas: OncologyCardiovascular
Modalities: Molecular Diagnostic
Industry: Molecular Diagnostics

Partnerships

Althea Technologies

Beyond the preview

Go deeper on Prediction Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prediction Sciences.

Explore the full profile